Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anne Tvilum"'
Autor:
Anne Tvilum, Mikkel I. Johansen, Lærke N. Glud, Diana M. Ivarsen, Amanda B. Khamas, Sheiliza Carmali, Snehit Satish Mhatre, Ane B. Søgaard, Emma Faddy, Lisanne deVor, Suzan H. M. Rooijakkers, Lars Østergaard, Nis P. Jørgensen, Rikke L. Meyer, Alexander N. Zelikin
Publikováno v:
Advanced Science, Vol 10, Iss 23, Pp n/a-n/a (2023)
Abstract The treatment of implant‐associated bacterial infections and biofilms is an urgent medical need and a grand challenge because biofilms protect bacteria from the immune system and harbor antibiotic‐tolerant persister cells. This need is a
Externí odkaz:
https://doaj.org/article/c14c4fbfa5824745a650ffdb22b17f9d
Autor:
Pere Monge, Anne Tvilum, Ane Bretschneider Søgaard, Kaja Borup Løvschall, Morten T. Jarlstad Olesen, Alexander N. Zelikin
Publikováno v:
Advanced Science, Vol 7, Iss 18, Pp n/a-n/a (2020)
Abstract The newest generation of cell‐based technologies relies heavily on methods to communicate to the engineered cells using artificial receptors, specifically to deactivate the cells administered to a patient in the event of adverse effects. H
Externí odkaz:
https://doaj.org/article/60838a236f924969a9b1ba8983753d9e
Autor:
Anne Tvilum, Mikkel I. Johansen, Lærke N. Glud, Diana M. Ivarsen, Amanda B. Khamas, Sheiliza Carmali, Snehit Satish Mhatre, Ane B. Søgaard, Emma Faddy, Lisanne de Vor, Suzan H.M. Rooijakkers, Lars Østergaard, Nis P. Jørgensen, Rikke L. Meyer, Alexander N. Zelikin
Implant-associated infections remain a grand unmet medical need because they involve biofilms that protect bacteria from the immune system and harbour antibiotic-tolerant persister cells. There is an urgent need for new biofilm-targeting therapies wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41e1ca67e32d92af060d6020e9320d73
https://doi.org/10.1101/2023.01.16.524127
https://doi.org/10.1101/2023.01.16.524127
Autor:
Jan Münch, Frederik Dagnæs-Hansen, Raoul Walther, Cecilie Domar, Anna H. F. Andersen, Paul W. Denton, Martin Tolstrup, Alexander N. Zelikin, Franziska Krüger, Anne Tvilum, Camilla Kaas Frich, Søren R. Paludan
Publikováno v:
Frich, C K, Krüger, F, Walther, R, Domar, C, Andersen, A H F, Tvilum, A, Dagnæs-Hansen, F, Denton, P W, Tolstrup, M, Paludan, S R, Münch, JJ & Zelikin, A N 2019, ' Non-covalent hitchhiking on endogenous carriers as a protraction mechanism for antiviral macromolecular prodrugs ', Journal of Controlled Release, vol. 294, pp. 298-310 . https://doi.org/10.1016/j.jconrel.2018.12.016
Albumin is a highly successful tool of drug delivery providing drastically extended body and blood residence time for the associated cargo, but it only traffics single drug copies at a time. In turn, macromolecular prodrugs (MP) are advantaged in car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13e0f885ad2a9b45030651b6a787eada
https://pure.au.dk/portal/da/publications/noncovalent-hitchhiking-on-endogenous-carriers-as-a-protraction-mechanism-for-antiviral-macromolecular-prodrugs(50d7e7f5-a0ad-4a19-9f82-22c015626a7d).html
https://pure.au.dk/portal/da/publications/noncovalent-hitchhiking-on-endogenous-carriers-as-a-protraction-mechanism-for-antiviral-macromolecular-prodrugs(50d7e7f5-a0ad-4a19-9f82-22c015626a7d).html